You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Express Scripts
Johnson and Johnson
McKesson
Harvard Business School
AstraZeneca
Baxter

Last Updated: March 4, 2021

DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR SODIUM TETRADECYL SULFATE

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

All Clinical Trials for Sodium Tetradecyl Sulfate

Trial ID Title Status Sponsor Phase Start Date Summary
NCT01347294 Compare Two Different Sclerosing Agents in the Treatment of Venous Malformations Unknown status Oslo University Hospital Phase 4 2011-08-01 The purpose of this study is to determine the effectiveness of bleomycin, fibrovein and bleomycin and fibrovein in the treatment of venous malformation.
NCT01408732 Office-sclerotherapy for Epistaxis Due to Hereditary Hemorrhagic Telangiectasia Completed American Rhinologic Society N/A 2011-02-01 The purpose of this study is to test a novel and tolerable office-based treatment method, sclerotherapy with sodium tetradecyl sulfate, for recurrent epistaxis (nosebleeds) related to Hereditary Hemorrhagic Telangiectasia (HHT) disease.
NCT01408732 Office-sclerotherapy for Epistaxis Due to Hereditary Hemorrhagic Telangiectasia Completed University of Minnesota - Clinical and Translational Science Institute N/A 2011-02-01 The purpose of this study is to test a novel and tolerable office-based treatment method, sclerotherapy with sodium tetradecyl sulfate, for recurrent epistaxis (nosebleeds) related to Hereditary Hemorrhagic Telangiectasia (HHT) disease.
NCT03311269 A Study Evaluating ClariVein With a Sclerosing Agent for the Treatment of Venous Insufficiency Recruiting Vascular Insights, LLC Phase 2 2017-09-22 VICARES is a prospective randomized, controlled, multi-center, double blind study treating venous insufficiency associated with incompetent saphenous veins with 1% and 3% Sodium Tetradecyl Sulfate (STS) solution utilizing the ClariVein system.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for Sodium Tetradecyl Sulfate

Condition Name

Condition Name for Sodium Tetradecyl Sulfate
Intervention Trials
Cost Effectiveness 1
Venous Insufficiency 1
Cosmesis 1
Pain 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for Sodium Tetradecyl Sulfate
Intervention Trials
Telangiectasia, Hereditary Hemorrhagic 1
Varicose Veins 1
Epistaxis 1
Hemorrhoids 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for Sodium Tetradecyl Sulfate

Trials by Country

Trials by Country for Sodium Tetradecyl Sulfate
Location Trials
United States 2
Pakistan 1
Norway 1
Portugal 1
Finland 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for Sodium Tetradecyl Sulfate
Location Trials
New Jersey 1
Minnesota 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for Sodium Tetradecyl Sulfate

Clinical Trial Phase

Clinical Trial Phase for Sodium Tetradecyl Sulfate
Clinical Trial Phase Trials
Phase 4 1
Phase 2 2
N/A 2
[disabled in preview] 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for Sodium Tetradecyl Sulfate
Clinical Trial Phase Trials
Recruiting 4
Completed 1
Unknown status 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for Sodium Tetradecyl Sulfate

Sponsor Name

Sponsor Name for Sodium Tetradecyl Sulfate
Sponsor Trials
University of Minnesota - Clinical and Translational Science Institute 1
American Rhinologic Society 1
Oslo University Hospital 1
[disabled in preview] 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for Sodium Tetradecyl Sulfate
Sponsor Trials
Other 6
Industry 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKinsey
AstraZeneca
McKesson
Moodys
Baxter
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.